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	 The	total	synthesis	of	pectinolide	H	and	4'‐epi‐pectinolide	H	was	accomplished	with	27%	yieldin	 nine	 steps	 from	 inexpensive	 and	 commercially	 available	 compound,	 (+)‐diethyl	 tartrate
((+)DET))	 by	 employing	 swern	 oxidation,	 Wittig	 olefination,	 Grignard	 and	 lactonization
reactions.	
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1.	Introduction	
	
Pectinolide	H	(1)	(Figure	1)	isolated	from	aerial	parts	of	a	
Mexican	 terrestrial	 plant	Hyptis	pectinata	 displays	 significant	
antimicrobial	 activity	 against	 a	 panel	 of	 multidrug‐resistant	
strains	 of	 Staphylococcus	 aureus	 [1].	 The	molecule	 possesses	
an	 α,β‐unsaturated	 γ‐lactone	motif	 common	 to	many	 natural	
products	 exhibiting	 antibacterial	 and	 anti‐inflammatory	
activities.	Many	compounds	with	similar	 structures	have	also	
been	reported	to	be	potentially	useful	as	anticancer	agents	and	
enzyme	 inhibitors	 [2‐10].	Considering	 the	 importance	of	new	
antimicrobial	 agents	 for	multidrug	 resistant	microorganisms,	
synthesis	 of	molecules	 such	 as	Pectinolide	H	 in	 a	 simple	 and	
straightforward	manner	is	necessary.		
To	 the	 best	 of	 our	 knowledge,	 two	 reports	 exist	 for	 the	
synthesis	 of	 pectinolide	 H	 (1)	 [11,12].	 Herein,	 we	 report	 an	
easy	approach	to	compound	1	carried	out	in	nine	simple	steps.	
Our	 synthetic	 strategy	 also	 provides	 the	 epimer	 4'‐epi‐
pectinolide	H	(2).	
	
2.	Experimental	
	
All	commercially	available	chemicals	were	purchased	from	
Sigma	Aldrich	and	used	without	purification.	All	 experiments	
were	carried	out	under	an	inert	nitrogen	atmosphere.	
	
	
2.1.	Instrumentation	
	
1H	and	13C	NMR	spectra	were	recorded	on	Bruker	Avance	
300	MHz	and	Bruker	Avance	75	MHz	spectrometers,	respect‐
tively,	 using	 CDCl3	 as	 solvent	 and	 SiMe4	 as	 the	 internal	
standard.	FT‐IR	analyses	were	performed	using	Perkin	Elmer	
RX1	 FT‐IR	 spectrophotometer.	 Mass	 spectra	 analyses	 were	
performed	on	VG	Auto	spec	instrument.	Optical	rotations	were	
determined	using	Jasco	Dip	360	digital	polarimeter.		
	
2.2.	Synthesis	
	
2.2.1.	Synthesis	of	diethyl	(4R,5R)‐2,2‐dimethyl‐1,3‐
dioxolane‐4,5‐dicarboxylate	(7)	
	
A	 solution	 of	 compound	6	 (10	 g,	 48.54	mmol),	p‐toluene	
sulfonic	 acid	 (100	 mg)	 in	 CH2Cl2	 (100	 mL)	 and	 2,2‐
dimethoxypropane	 (12	 mL,	 97	 mmol)	 was	 stirred	 at	 room	
temperature	for	4	h.	The	reaction	mixture	was	quenched	with	
solid	NaHCO3,	filtered,	solvent	was	evaporated	under	vacuum.	
The	 crude	 product	 was	 purified	 by	 flash	 column	 chroma‐
tography	(Hexane:EtOAc,	98:2,	v:v)	to	give	compound	7.	Color:	
Colorless	 liquid.	 Yield:	 10.75	 g,	 90%.	 FT‐IR	 (Neat,	 ν,	 cm‐1):	
2990,	1753,	1216.	1H	NMR	(300	MHz,	CDCl3,	δ,	ppm):	1.31	(t,	
6H,	 CH3‐CH2‐O),	 1.50	 (s,	 6H,	 (CH3)2C),	 4.27	 (q,	 4H,	 CH2‐OCO),	
4.76	(s,	2H,	CH‐COO).		
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Figure	1.	Structure	of	pectinolide	A‐C,	H	and	4‐epi‐pectinolide	H.	
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Reagents	and	conditions:	a)	2,2‐DMP,	PTSA(cat.)	CH2Cl2,	rt,	4	h,	90	%.	b)	LiAlH4,	THF,	0	 °C	 to	rt,	1	h,	85%.	c)	TBDPSCl,	NaH,	THF,	0	 °C	 to	rt,	2h,	90%.	d)	 (i)	
(COCl)2,	DMSO,	CH2Cl2,	Et3N,	‐78	°C.	(ii)	Ph3PCHCOOEt,	MeOH,	‐50	°C	to	rt,	(88%	in	two	steps).	e)	DIBAL‐H,	CH2Cl2,	‐78	°C,	30	min.	f)	Mg,	nBuBr,	THF,	(66%	in	
two	steps).	g)	Ac2O,	DMAP,	Pyridine,	CH2Cl2,	rt,	3	h,	99%.	h)	TBAF,	THF,	rt,	5	h,	92%.	i)	(i)	(COCl)2,	DMSO,	CH2Cl2,	Et3N,	‐78	°C.	(ii)	(F3CCH2O)2POCH2COOEt,	18‐
crown	ether,	KHMDS,	dry	THF,	‐78	°C,	4	h,	(80%	in	two	steps).	j)	TsOH,	MeOH,	2	h,	93%.	
	
Scheme	1
	
	
13C	NMR	(75	MHz,	CDCl3,	δ,	ppm):	13.9,	26.2,	61.7,	76.9,	113.5,	
169.5.	ESI‐MS	(m/z):	247	(M+1)+,	269	(M+Na)+.	
	
2.2.2.	Synthesis	of	((4S,5S)‐2,2‐dimethyl‐1,3‐dioxolane‐4,5‐
diyl)dimethanol	(8)	
	
A	solution	of	compound	7	(6	g,	24.4	mmol)	in	THF	(20	mL)	
was	slowly	added	to	a	suspension	of	LiAlH4	(3.7	g,	97.5	mmol)	
in	 THF	 (100	 mL)	 at	 0	 °C	 over	 a	 period	 of	 20	 min	 under	
nitrogen	atmosphere.	After	2	h,	aqueous	NH4Cl	 (10%,	w:v,	20	
mL)	was	added	and	the	reaction	mixture	was	filtered	through	
celite.	 The	 filtrate	 was	 dried	 over	 anhydrous	 MgSO4	 and	
evaporated	under	vacuum.	The	crude	product	was	purified	by	
flash	column	chromatography	using	EtOAc	as	eluent	to	afford	
pure	 compound	 8	 (Scheme	 1).	 Color:	 Colorless	 liquid.	 Yield:	
3.35	 g,	 85%.	 FT‐IR	 (Neat,	 ν,	 cm‐1):	 3403.	 1H	NMR	 (300	MHz,	
CDCl3,	 δ,	 ppm):	 1.43	 (s,	 6H,	 (CH3)2C),	 2.77	 (br.	 s,	 2H,	 2	 ‐OH),	
3.68‐3.81	(m,	4H,	CH2‐OH),	3.98‐3.99	(m,	2H,	CH‐CH2‐OH).	13C	
NMR	(75	MHz,	CDCl3,	δ,	ppm):	δ	26.9,	62.0,	78.1,	109.2.	ESI‐MS	
(m/z):	162	(M+).	[α]D25:	‐8.16	(c	1,	CHCl3).	
	
2.2.3.	Synthesis	of	((4S,5S)‐5‐((tert‐butyldiphenylsilyloxy)	
methyl)‐2,2‐dimethyl‐1,3‐dioxolan‐4‐yl)	methanol	(9)	
	
To	 a	 stirred	 solution	 of	 diol	 (8)	 (1.62	 g,	 10	 mmol)	 in	
anhydrous	THF	(50	mL),	NaH	(264	mg,	11	mmol)	was	added	at	
0	°C	under	nitrogen	atmosphere	and	the	contents	were	stirred	
for	 30	 min.	 A	 solution	 of	 tert‐butylchlorodiphenylsilane	
(TBDPS‐Cl)	(2.74	g,	10	mmol)	dissolved	in	anhydrous	THF	(20	
mL)	 was	 added	 and	 stirring	 was	 continued	 for	 2	 h	 at	 room	
temperature.	The	 reaction	mixture	was	quenched	with	water	
(40	mL)	and	THF	was	evaporated.	The	residue	was	extracted	
with	 CH2Cl2	 (3×10	 mL),	 dried	 over	 anhydrous	 MgSO4,	 and	
concentrated	under	vacuum.	The	crude	product	was	subjected	
to	 flash	 column	 chromatography	 (Hexane:EtOAc,	 4:1,	 v:v)	 to	
afford	compound	9	(Scheme	1).	Color:	Colorless	oil.	Yield:	3.6	
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g,	 90%.	 FT‐IR	 (Neat,	 ν,	 cm‐1):	 3466,	 2931,	 1428,	 1245,	 1080,	
702.	 1H	NMR	(300	MHz,	CDCl3,	δ,	ppm):	1.06	 (s,	9H,	 (CH3)3C‐
Si),	1.38	(s,	3H,	CH3‐C‐O),	1.41	(s,	3H,	CH3‐C‐O),	3.63‐3.84	(m,	
4H,	 CH2‐OH,	 CH2‐OSi),	 3.93‐3.99	 (m,	 1H,	 CH‐CH2‐OH),	 4.04‐
4.10	 (m,	 1H,	 CH‐CH2‐OSi),	 7.36‐7.43	 (m,	 6H,	 Ar‐H),	 7.64‐7.68	
(m,	 4H,	 Ar‐H).	 13C	 NMR	 (75	MHz,	 CDCl3,	 δ,	 ppm):	 19.1,	 26.7,	
26.9,	 27.0,	 62.5,	 64.1,	 77.4,	 79.5,	 109.1,	 127.7,	 127.8,	 129.8,	
129.9,	132.8,	135.5.	ESI‐MS	(m/z):	423	(M+Na)+.	[α]D25:	‐1.5	(c	
14.5,	CHCl3).	
	
	2.2.4.	Synthesis	of	(Z)‐ethyl	3‐((4S,5S)‐5‐((tert‐butyl	
diphenylsilyloxy)methyl)‐2,2‐dimethyl‐1,3‐dioxolan	‐4‐yl)	
acrylate	(10a)	and	(E)‐ethyl	3‐((4S,5S)‐5‐((tert‐butyl	
diphenylsilyloxy)	methyl)‐2,2‐dimethyl‐1,3‐dioxolan‐4‐yl)	
acrylate	(10b)	
	
To	 a	 solution	 of	 oxalyl	 chloride	 (0.7	mL,	 8	mmol)	 in	 dry	
CH2Cl2	 (20	 mL),	 DMSO	 was	 added	 drop‐wise	 (1.14	 mL,	 16	
mmol)	at	 ‐78	°C	over	20	min	under	nitrogen	atmosphere	and	
stirred	 for	 30	min	 at	 the	 same	 temperature.	 To	 this	 reaction	
mixture,	 compound	9	(1.6	g,	4	mmol)	 in	CH2Cl2	(5.0	mL)	was	
added	drop‐wise	over	15	min	at	‐78	°C,	and	resulting	mixture	
was	 stirred	 for	 3	 h	 at	 same	 temperature.	 The	 reaction	 was	
quenched	 with	 Et3N	 (5.0	 mL)	 and	 allowed	 to	 reach	 room	
temperature	 over	 30	 min.	 The	 solvent	 was	 removed	 on	
rotavapor	 and	 the	 residue	 was	 purified	 by	 a	 flash	 column	
chromatography	 (Hexane:EtOAc,	 10:1,	 v:v)	 to	 obtain	 crude	
aldehyde	which	was	employed	in	the	next	step	immediately.		
The	 solution	 of	 crude	 aldehyde	 (1.52	 g,	 3.82	 mmol)	 in	
MeOH	(15	mL)	was	added	to	a	solution	of	Ph3P=CHCOOEt	(4	g,	
11.5	mmol)	 in	MeOH	 (100	mL)	 at	 ‐50	 °C	 drop‐wise	 over	 30	
min.	 The	 resulting	 solution	 was	 stirred	 for	 1	 h	 at	 same	
temperature,	 diluted	 with	 water	 and	 extracted	 with	 CH2Cl2	
(3×25	 mL).	 The	 organic	 layer	 was	 dried	 over	 anhydrous	
MgSO4	 and	 the	 solvent	 was	 removed	 under	 vacuum.	 The	
residue	 was	 purified	 by	 flash	 column	 chromatography	
(Hexane:EtOAc,	50:1,	v:v)	 to	obtain	pure	compounds	10a	and	
10b	in	80:20	ratio	(Scheme	1).		
(Z)‐Ethyl	 3‐((4S,5S)‐5‐((tert‐butyldiphenylsilyloxy)methyl)‐
2,2‐dimethyl‐1,3‐dioxolan	‐4‐yl)acrylate	(10a):	Color:	Colorless	
oil.	Yield:	1.32	g,	70%.	FT‐IR	(Neat,	ν,	cm‐1):	2932,	1720,	1111.	
1H	 NMR	 (300	 MHz,	 CDCl3,	 δ,	 ppm):	 1.04	 (s,	 9H,	 (CH3)3C‐Si),	
1.21	 (t,	 3H,	 CH3‐CH2‐O),	 1.432	 (s,	 3H,	 CH3‐C‐O),	 1.439	 (s,	 3H,	
CH3‐C‐O),	3.80‐3.88	(m,	3H,	CH2‐OSi,	CH‐CH2‐OSi),	4.07	(q,	2H,	
CH2‐OCO),	5.44‐5.52	(m,	1H,	CH‐CH=CH),	5.86	(dd,	1H,	J	=	10.5,	
1.5	 Hz,	 HC‐COO),	 6.12	 (dd,	 1H,	 J	 =	 9.0,	 3.0	 Hz,	 HC=CH‐COO),	
7.32‐7.43	(m,	6H,	Ar‐H),	7.67‐7.69	(m,	4H,	Ar‐H).	13C	NMR	(75	
MHz,	 CDCl3,	 δ,	 ppm):	 14.1,	 19.1,	 26.7,	 27.0,	 27.1,	 60.3,	 64.1,	
73.4,	82.1,	117.0,	122.9,	127.5,	127.7,	129.5,	130,	135.6,	135.7,	
145.3,	 (C=O	 not	 seen).	 ESI‐MS	 (m/z):	 469	 (M+1)+,	 491	
(M+Na)+.	
(E)‐Ethyl	3‐((4S,5S)‐5‐((tert‐butyldiphenylsilyloxy)	methyl)‐
2,2‐dimethyl‐1,3‐dioxolan‐4‐yl)acrylate	 (10b):	 Color:	 Colorless	
oil.	Yield:	0.33	g,	18%.	FT‐IR	(Neat,	ν,	cm‐1):	2933,	1719,	1112.	
1H	 NMR	 (300	 MHz,	 CDCl3,	 δ,	 ppm):	 1.07	 (s,	 9H,	 (CH3)3C‐Si),	
1.29	(t,	3H,	CH3‐CH2‐O),	1.4	(s,	3H,	CH3‐C‐O),	1.44	(s,	3H,	CH3‐C‐
O),	3.81‐3.88	 (m,	 3H,	 CH2‐OSi,	 CH‐CH2‐OSi),	 4.20	 (q,	 2H,	 CH2‐
OCO),	4.57‐4.62	(m,	1H,	CH‐CH=CH),	6.10	(dd,	1H,	J	=	15.8,	1.5	
Hz,	HC‐COO),	6.93	(dd,	1H,	J	=	10.5,	5.2	Hz,	HC=CH‐COO	),	7.35‐
7.43	(m,	6H,	Ar‐H),	7.65‐7.70	(m,	4H,	Ar‐H).	13C	NMR	(75	MHz,	
CDCl3,	 δ,	 ppm):	 14.2,	 19.1,	 26.7,	 26.9,	 27.0,	 60.4,	 63.1,	 77.4,	
80.7,	 109.8,	 122.1,	 127.5,	 127.7,	 129.5,	 129.7,	 132.8,	 135.5,	
135.7,	144.4,	165.9.	ESI‐MS	(m/z):	469	(M+1)+,	491	(M+Na)+.	
	
2.2.5.	Synthesis	of	(Z)‐1‐((4S,5S)‐5‐((tert‐butyldiphenylsilyl	
oxy)methyl)‐2,2‐dimethyl‐1,3‐dioxolan‐4‐yl)hept‐1‐en‐3‐ol	
(12)	
	
To	a	stirred	solution	of	compound	10a	(2.0	g,	4.27	mmol)	
in	 CH2Cl2	 (50	 mL),	 diisobutylaluminium	 hydride	 (DIBAL‐H)	
(2.48	mL,	4.27	mmol)	was	added	drop‐wise	at	‐78	°C,	and	the	
reaction	mixture	was	stirred	for	30	min	at	same	temperature.	
The	reaction	was	quenched	with	aqueous	MeOH	(10	mL,	50%,	
v:v)	at	0	°C.	Saturated	sodium	potassium	tartrate	solution	(10	
mL)	was	added	and	 the	contents	were	extracted	with	CH2Cl2.	
The	combined	organic	layer	was	dried	over	anhydrous	MgSO4,	
concentrated	under	vacuum	 to	obtain	 the	crude	aldehyde	11	
which	was	used	in	next	step	without	further	purification.		
A	solution	of	n‐butyl	bromide	(0.92	mL,	8.54	mmol)	in	THF	
(5	mL)	was	added	to	a	suspension	of	Mg	(0.2	g,	8.33	mmol)	in	
THF	 (30	mL)	 and	 refluxed	 for	 20	min.	 The	 reaction	mixture	
was	cooled	 to	0	°C	and	solution	of	crude	aldehyde	11	 in	THF	
(10	mL)	was	added.	After	1	h	the	reaction	was	quenched	with	
aqueous	NH4Cl,	filtered	through	a	celite.	The	filtrate	was	dried	
anhydrous	 MgSO4,	 concentrated	 under	 vacuum,	 and	 purified	
by	flash	column	chromatography	(Hexane:EtOAc,	80:20,	v:v)	to	
afford	diastereoisomeric	mixture	of	compound	12	(Scheme	1).	
Color:	Pale	yellow	oil.	Yield:	1.36	g.	66%.	FT‐IR	(Neat,	ν,	cm‐1):	
3441,	 2931,	 1428,	 1113.	 1H	 NMR	 (300	MHz,	 CDCl3,	 δ,	 ppm):	
0.89	 (t,	 3H,	 CH3‐CH2‐),	 1.06	 (s,	 9H,	 (CH3)3C‐Si),	 1.23‐1.37	 (m,	
4H,	CH2‐CH2‐CH3),	1.43	(s,	6H,	(CH3)2C),	1.46‐1.53	(m,	2H,	CH2‐
(CH2)2‐CH3),	 3.69‐3.86	 (m,	 3H,	 CH2‐OSi,	 CH‐CH2‐OSi),	 4.09	 (q,	
1H,	CH(OH)),	4.43	(t,	1H,	HC‐CH=),	5.65	(dd,	1H,	J	=	8.3,	6.7	Hz,	
=CH‐CH(OH)),	 5.78	 (dd,	 1H,	 J	 =	 9.8,	 6.0	 Hz,	 CH=CH‐CH(OH)),	
7.35‐7.43	(m,	6H,	Ar‐H),	7.65‐7.70	(m,	4H,	Ar‐H).	13C	NMR	(75	
MHz,	 CDCl3,	 δ,	 ppm):	 13.9,	 19.2,	 22.5,	 26.7,	 26.9,	 27.0,	 27.4,	
36.6,	 62.7,	 71.9,	 78.0,	 81.4,	 109.0,	 127.4,	 127.6,	 129.6,	 129.7,	
133.1,	135.6,	137.5.	ESI‐MS	(m/z):	505	(M+Na)+.	HRMS	calcd.	
for	C29H42O4NaSi	[M+Na]+:	505.27446,	Found:	505.27282.	
	
2.2.6.	Synthesis	of	(Z)‐1‐((4S,5S)‐5‐((tert‐butyldiphenylsilyl	
oxy)methyl)‐2,2‐dimethyl‐1,3‐dioxolan‐4‐yl)hept‐1‐en‐3‐yl	
acetate	(13)	
	
To	a	stirred	solution	of	alcohol	12	(482	mg,	1.03	mmol)	in	
CH2C12	 (10	 mL)	 were	 added	 catalytic	 amount	 (5	 mg)	 of	 4‐	
dimethylaminopyridine	(DMAP)	and	pyridine	(0.126	mL,	1.55	
mmol)	 at	 0	 °C.	 Under	 stirring	 at	 same	 temperature,	 acetic	
anhydride	(0.147	mL,	1.55	mmol)	was	added	and	the	resulting	
mixture	was	stirred	for	3	h	at	room	temperature.	The	reaction	
mixture	was	 quenched	with	 aqueous	NaHCO3	 solution	 (10%,	
w:v,	 5	mL),	 and	 extracted	with	 EtOAc.	 The	 organic	 layer	was	
dried	over	anhydrous	MgSO4,	concentrated	under	vacuum,	and	
purified	by	flash	column	chromatography	(Hexane:EtOAc,	9:1,	
v:v)	 to	 afford	 compound	13	 (Scheme	 1).	 Color:	 Colorless	 oil.	
Yield:	 0.54	 g,	 99%.	 FT‐IR	 (Neat,	 ν,	 cm‐1):	 2932,	 1740,	 1238,	
1113.	1H	NMR	(300	MHz,	CDCl3,	δ,	ppm):	0.87	(t,	3H,	CH3‐CH2‐
),	1.06	(s,	9H,	(CH3)3C‐Si),	1.20‐1.34	(m,	4H,	CH2‐CH2‐CH3),	1.43	
(s,	6H,	(CH3)2C),	1.51‐1.65	(m,	2H,	CH2‐(CH2)2‐CH3),	2.05	(s,	3H,	
CH3‐CO),	3.68‐3.84	(m,	3H,	CH2‐OSi,	CH‐CH2‐OSi),	4.44‐4.50	(m,	
1H,	 HC‐CH=),	 5.21‐5.27	 (m,	 1H,	 CH(OAc)),	 5.68‐5.72	 (m,	 2H,	
CH=CH),	7.35‐7.43	(m,	6H,	Ar‐H),	7.65‐7.70	(m,	4H,	Ar‐H).	13C	
NMR	(75	MHz,	CDCl3,	δ,	ppm):	13.8,	19.1,	21.1,	22.3,	26.7,	26.8,	
26.9,	27.1,	33.9,	62.5,	73.5,	77.8,	81.2,	109,	127.6,	129.4,	129.6,	
131.9,	 133.0,	 135.5,	 170.	 ESI‐MS	 (m/z):	 547	 (M+Na)+.	 HRMS	
calcd.	for	C31H44O5SiNa	[M+Na]+:	547.2964,	Found:	547.2954.	
	
2.2.7.	Synthesis	of	(Z)‐1‐((4S,5S)‐5‐(hydroxymethyl)‐2,2‐
dimethyl‐1,3‐dioxolan‐4‐yl)hept‐1‐en‐3‐yl	acetate	(14)	
	
To	a	stirred	solution	of	compound	13	(945	mg,	1.8	mmol)	
in	dry	THF	(20	mL),	TBAF	(5.45	mL,	1	M	in	THF,	5.41	mmol)	
was	added	at	room	temperature	and	the	resulting	solution	was	
stirred	for	5	h.	The	solvent	was	evaporated	under	vacuum	and	
purified	by	flash	column	chromatography	(Hexane:EtOAc,	6:1,	
v:v)	 to	 afford	 compound	14	 (Scheme	 1).	 Color:	 Colorless	 oil.	
Yield:	 0.493	 g,	 92%.	 FT‐IR	 (Neat,	 ν,	 cm‐1):	 3451,	 2934,	 2873,	
1738,	1240,	1048.	1H	NMR	(300	MHz,	CDCl3,	δ,	ppm):	0.89	(t,	
3H,	 CH3‐CH2),	 1.25‐1.36	 (m,	 4H,	 CH2‐CH2‐CH3),	 1.43	 (s,	 6H,	
(CH3)2C),	1.59‐1.63	(m,	2H,	CH2‐(CH2)2‐CH3),	2.04	(s,	3H,	CH3‐
CO),	3.55‐3.85	(m,	3H,	CH2‐OH,	CH‐CH2‐OH),	4.32	(m,	1H,	HC‐
CH=),	 5.25	 (m,	 1H,	 CH(OAc)),	 5.63‐5.83	 (m,	 2H,	 CH=CH).	 13C	
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NMR	 (75	MHz,	 CDCl3,	 δ,	 ppm):	 13.8,	 21.2,	 22.3,	 26.90,	 26.99,	
27.2,	 33.9,	 60.5,	 73.6,	 77.2,	 81.0,	 109.3,	 129.1,	 133.3,	 170.3.	
ESI‐MS	 (m/z):	 287	 (M+1)+,	 309	 (M+Na)+.	 HRMS	 calcd.	 for	
C15H27O5	[M+H]+:	287.1781,	Found:	287.1652.	
	
2.2.8.	Synthesis	of	(Z)‐ethyl	3‐((4S,5S)‐5‐((Z)‐3‐acetoxyhept‐
1‐enyl)‐2,2‐dimethyl‐1,3‐dioxolan‐4‐yl)acrylate	(15)	
	
To	a	stirred	solution	of	(COCl)2	(0.25	mL,	2.8	mmol)	in	dry	
CH2Cl2	 (30	 mL)	 was	 added	 anhydrous	 DMSO	 (0.4	 mL,	 5.6	
mmol)	 at	 ‐78	 °C	 over	 a	 period	 of	 20	 min	 under	 nitrogen	
atmosphere,	and	the	reaction	mixture	was	stirred	for	30	min.	
A	solution	of	compound	14	(400	mg,	1.4	mmol.)	in	CH2Cl2	was	
added	and	the	resulting	solution	was	stirred	for	1	h	at	‐78	°C.	
The	 reaction	 was	 quenched	 with	 Et3N	 (1.17	 mL,	 8.4	 mmol),	
allowed	 to	 reach	 room	 temperature	 and	 then	 extracted	with	
CH2Cl2.	The	combined	organic	layer	was	dried	over	anhydrous	
MgSO4	 and	 evaporated	 under	 vacuum	 to	 obtain	 crude	
aldehyde	which	was	employed	to	the	next	step	immediately.	
To	 a	 stirred	 solution	 of	 (F3CCH2O)2POCH2COOEt	 (0.354	
mL,	1.67	mmol),	18‐crown‐6	(1.478	g,	5.6	mmol)	in	dry	THF	(2	
mL)	 at	 ‐78	 °C	was	 added	 KHMDS	 (0.362	 g,	 1081	mmol)	 and	
stirred	 for	30	min.	The	solution	of	 crude	aldehyde	 in	THF	 (5	
mL)	was	added,	 reaction	mixture	was	stirred	 for	4	h	at	same	
temperature.	 The	 reaction	 was	 quenched	 with	 saturated	
aqueous	NH4Cl	 (5	mL)	 and	 extracted	with	 ethyl	 acetate.	 The	
combined	 organic	 layers	 were	 dried	 over	 anhydrous	 MgSO4,	
concentrated	under	vacuum,	and	 the	 residue	was	purified	by	
flash	 column	 chromatography	 (Hexane:EtOAc,	 8:2,	 v:v)	 to	
afford	 compound	 15	 (Scheme	 1).	 Color:	 Colorless	 oil.	 Yield:	
0.396	 g,	 80%.	 FT‐IR	 (Neat,	 ν,	 cm‐1):	 2937,	 1725,	 1371,	 1234,	
1048.	 1H	 NMR	 (300	 MHz,	 CDCl3,	 δ,	 ppm):	 0.88	 (t,	 3H,	 CH3‐
(CH2)2),	1.25‐1.31	(m,	7H,	((CH2)2‐CH3,	CH3‐CH2‐O),	1.45	(s,	6H,	
(CH3)2C),	 1.53‐1.66	 (m,	 2H,	 CH2‐(CH2)2‐CH3),	 2.0	 (s,	 3H,	 CH3‐
CO),	 4.03‐4.22	 (m,	 3H,	 O‐CH2‐CH3,	 CH‐CH=CH),	 5.22‐5.30	 (m,	
1H,	 CH‐CH=CH‐COO),	 5.38‐5.46	 (m,	 1H,	 CH(OAc)),	 5.71‐5.76	
(m,	2H,	CH=CH‐CH(OAc)),	5.93	(d,	1H,	J	=	11.3	Hz,	CH‐COOEt),	
6.12	(dd,	1H,	J	=	8.3,	3.0	Hz,	HC=CH‐COOEt).	13C	NMR	(75	MHz,	
CDCl3,	δ,	ppm):	13.8,	14.0,	21.1,	22.3,	26.9,	27.01,	27.06,	33.8,	
60.2,	73.2,	75.8,	81.4,	109.8,	123.3,	127.9,	133.2,	143.8,	164.9,	
170.0.	ESI‐MS	(m/z):	377	(M+Na)+.	HRMS	calcd.	for	C19H30O6Na	
[M+Na]+:	377.2042,	Found:	377.1987.	
	
2.2.9.	Synthesis	of	pectinolide	H	(1)	and	4‐epi‐pectinolide	H	
(2)	
	
A	solution	of	compound	15	(25	mg,	0.706	mmol)	in	MeOH	
(10	mL)	was	stirred	with	a	catalytic	amount	of	PTSA	(2	mg)	at	
room	 temperature.	 After	 4	 h	MeOH	was	 evaporated	 and	 the	
crude	 product	 was	 purified	 by	 preparative	 thin	 layer	
chromatography	 (Hexane:	 EtOAc,	 1:1,	 v:v)	 to	 obtain	 pure	
compounds	1	and	2	in	1.2	:	1	ratio	(Scheme	1).	
(1S,4S,Z)‐1‐hydroxy‐1‐((S)‐5‐oxo‐2,5‐dihydrofuran‐2‐yl)oct‐
2‐en‐4‐yl	acetate	(Pectinolide	H)	(1):	Color:	Colorless	oil.	Yield:	
9.6	mg,	50.8	%.	FT‐IR	(Neat,	ν,	cm‐1):	3439,	2931,	2862,	1750,	
1241,	 1042.	 1H	 NMR	 (300	MHz,	 CDCl3,	 δ,	 ppm):	 0.89	 (t,	 3H,	
CH3‐(CH2)2),	 1.22‐1.36	 (m,	 4H,	 (CH2)2‐CH3),	 1.50‐1.70	 (m,	2H,	
CH2‐(CH2)2‐CH3),	2.06	(s,	3H,	CH3‐CO),	3.07	(br.	1H,	OH),	4.28‐
4.33	 (m,	 1H,	 CH‐OH),	 5.00‐5.04	 (m,	 1H,	 CH(OAc)),	 5.15‐5.22	
(m,	1H,	CH‐CH=CH‐COO),	5.62‐5.84	(m,	2H,	CH=CH‐CH(OAc)),	
6.19	(dd,	1H,	J	=	4.5,	1.5	Hz,	=CH‐COO),	7.47	(dd,	1H,	J	=	6.7,	1.5	
Hz,	CH=CH‐COO).	13C	NMR	(75	MHz,	CDCl3,	δ,	ppm):	13.8,	21.1,	
22.2,	 27.0,	 33.7,	 72.2,	 73.7,	 85.5,	 122.9,	 128.4,	 133.2,	 153.2,	
170.5,	172.6.	ESI‐MS	(m/z):	291	(M+Na)+.	[α]D25:	‐39.0	(c	0.32,	
CHCl3).	 HRMS	 calcd.	 for	 C14H20O5Na	 [M+Na]+:	 291.1202;	
Found:	291.1200.		
(1S,4R,Z)‐1‐hydroxy‐1‐((S)‐5‐oxo‐2,5‐dihydrofuran‐2‐yl)oct‐
2‐en‐4‐yl	acetate	(4‐epi‐pectinolide	H)	(2):	Color:	Colorless	oil.	
Yield:	 8	 mg,	 42.3%.	 FT‐IR	 (Neat,	 ν,	 cm‐1):	 3444,	 2928,	 2856,	
1750,	1241,	1043.	 1H	NMR	(300	MHz,	CDCl3,	δ,	ppm):	0.89	(t,	
3H,	 CH3‐(CH2)2),	 1.24‐1.31	 (m,	 4H,	 (CH2)2‐CH3),	 1.54‐1.68	 (m,	
2H,	 CH2‐(CH2)2‐CH3),	 2.06	 (s,	 3H,	 CH3‐CO),	 2.76	 (br.	 1H,	 OH),	
4.27‐4.30	 (m,	 1H,	 CH‐OH),	 4.99‐5.01	 (m,	 1H,	 CH(OAc)),	 5.18‐
5.24	 (m,	 1H,	 CH‐CH=CH‐COO),	 5.64‐5.84	 (m,	 2H,	 CH=CH‐
CH(OAc)),	6.18	(d,	1H,	 J	=	4.7	Hz,	=CH‐COO),	7.43	(dd,	1H,	 J	=	
5.7,	 4.7	 Hz,	 CH=CH‐COO).	 13C	 NMR	 (75	MHz,	 CDCl3,	 δ,	 ppm):	
13.8,	21.2,	22.3,	27.1,	33.8,	72.5,	73.7,	85.5,	123.0,	128.3,	133.5,	
153.1,	170.5,	172.5.	ESI‐MS	(m/z):	291	(M+Na)+.	 [α]D25:	+21.9	
(c	0.1,	CHCl3).	HRMS	calcd.	for	C14H20O5Na	[M+Na]+:	291.1202,	
Found:	291.1188.	
	
3.	Results	and	discussion		
	
A	cursory	look	at	the	structure	of	compound	1	shows	that	
(+)‐diethyl	 L‐tartrate	 (6)	 possesses	 the	 required	 (2S,3S)‐	
stereochemistry.	 Protection	 of	 the	 vicinal	 hydroxy	 groups	 as	
an	 acetonide	 and	 reduction	 of	 compound	7	with	 LiAlH4	 gave	
the	 corresponding	 diol	 (8)	 in	 85%	 yield.	 Selective	 mono‐
protection	of	compound	8	was	achieved	with	1	equiv.	of	(tert‐
butyl	 diphenylsilyl	 chloride	 (TBDPSCl)	 in	presence	of	NaH	 in	
THF.	 The	 mono	 protected	 alcohol	 (9)	 was	 oxidized	 to	 the	
corresponding	 aldehyde	 by	 Swern	 oxidation.	 The	 crude	
aldehyde	 was	 subjected	 to	Wittig	 olefination	 in	 methanol	 to	
obtain	 a	mixture	 of	E	 and	 Z‐alkene	 (10)	with	E	 to	 Z	 ratio	 of	
20:80.	 The	 isomers	 were	 easily	 separated	 by	 column	
chromatography	[13].	Reduction	of	the	ester	group	of	Z‐(10a)	
with	DIBAL‐H	in	CH2Cl2	and	Grignard	reaction	of	the	aldehyde	
(11)	 with	 n‐butyl	 magnesium	 bromide	 gave	 a	 diastereo‐
isomeric	mixture	of	secondary	alcohols	(12).	Acetylation	with	
Ac2O	 in	 pyridine	 provided	 a	 mixture	 of	 diastereomers	 (13).	
Deprotection	 of	 the	 primary	 alcohol	 with	 TBAF	 followed	 by	
Swern	 oxidation	 of	 the	 alcohol	 (14)	 gave	 an	 intermediate	
aldehyde	 which	 was	 subjected	 to	 Still‐Gennari	 olefination	
reaction	[14,15]	without	isolation	to	afford	the	corresponding	
α,β‐unsaturated	 ester	 (15)	 in	 80%	yield.	Deprotection	 of	 the	
acetonide	 and	 subsequent	 in	 situ	 lactonization	 of	 ester	 (15)	
with	p‐toluenesulfonic	acid	in	MeOH	afforded	a	diastereomeric	
mixture	 of	 pectinolide	 H	 (1)	 and	 4'‐epi‐pectinolide	 H	 (2)	 in	
98%	 yield	 (Scheme	 1).	 Both	 the	 diastereomers	were	 separa‐
ted	by	preparative	TLC.	The	1H	and	13C	NMR	spectral	data	and	
optical	 rotation	of	pectinolide	H	were	 in	 excellent	 agreement	
with	the	data	previously	reported	in	literature	[11,12].		
	
4.	Conclusion	
	
In	 conclusion,	 a	 simple	 stereoselective	 total	 synthesis	 of	
pectinolide	 H	 and	 4'‐epi‐pectinolide	 H	 have	 been	 achieved	
from	 (+)‐DET	 in	 nine	 steps	 with	 27%	 overall	 yield.	 Our	
synthetic	 strategy	 provides	 pectinolide	H	 and	 the	 epimer	 4'‐
epi‐pectinolide	H.	
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